North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 783 Jul 28 – Oct 25, 2026
- Disclosed funding
- $70B 628 disclosed amounts
- Median round
- $24.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AT Adjuvia TherapeuticsCompany profile Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. | $8M | Seed | Biotech | United States | Investors | |
| A ArchCompany profile Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. | $52M | Series B | Fintech | United States | Investors | |
| C ChipAgentsCompany profile ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. | $60M | Series A+Series A | Hardware | United States | Investors | |
| PB Physician-led behavioral health services and technology company | $14.2M | Growth | Healthtech | United States | Investors | |
| C CopySightCompany profile AI IP governance platform for copyright risk management in AI-generated content AI IP governance platform for copyright risk management in AI-generated content | $3M | Seed | Enterprise software | United States | Investors | |
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Biotech | United States | Investors | |
| EA Develops enterprise AI agents for revenue-generating customer interactions. | $30M | Series A | Enterprise software | United States | Investors | |
| OS Secure AI control plane for the enterprise. | $113M | Series B | Cybersecurity | United States | Investors | |
| D A software-first registered agent that automates state filings. | $10M | Series A | Enterprise software | United States | Investors | |
| T ThreatLockerCompany profile Zero Trust cybersecurity platform for endpoints, networks, and cloud systems Zero Trust cybersecurity platform for endpoints, networks, and cloud systems | $190M | Series FSeries C+ | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 28, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
58rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
42rounds16led - 3Khosla Ventures
Arda Industries, Tolan
26rounds6led - 4Sequoia Capital
Warhound, Whop, Blacksmith
23rounds7led - 5Alumni Ventures
Maxinsights, Daytona, Chariot Claims
22rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.